Sign in to view content

Percentage of Patients Maintained on Quarterly Anti-VEGF Dosing for the Treatment of Neovascular Age-Related Macular Degeneration Across Key Clinical Trials

David A. Eichenbaum, MD, FASRS

Video
Published 2018

Related

Outcomes of Antivascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice
Andrew A. Moshfeghi, MD, MBA, FASRS
Annual Meeting Talks
2018
Modified Flanged Scleral-Fixation for Intraocular Lens Insertion
Richard H. Johnston, MD
Annual Meeting Talks
2018
Randomized Trial of Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: 5-Year Outcomes
Jeffrey G. Gross, MD, FASRS
Annual Meeting Talks
2018

Category: Age-Related Macular Degeneration

See more